Article Details
Retrieved on: 2022-11-03 20:11:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced financial results for the third ...
Article found on: stockhouse.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here